Leader in Intelligent Orthopedic Diagnosis and Treatment Systems
Bone's Technology Limited (博志生物科技有限公司), abbreviated as "Bone's Technology," is a national high-tech enterprise specializing in intelligent diagnosis and treatment in the field of musculoskeletal health. The company is dedicated to using innovative digital and drug-device combination technologies to help prevent and treat musculoskeletal system diseases. Founded by professors, Ph.D. holders, and alumni of the University of Hong Kong, Bone's Technology is built upon 30 years of experience in orthopedics clinical practice, research, and industry. It was the first to propose the localized bone quality assessment theory, combining artificial intelligence and biomechanics to significantly enhance the precision of traditional bone density measurements from 60% to 99%.
Leveraging the next-generation bone quality assessment theory, Bone's Technology digitizes the human skeleton and has developed a comprehensive product matrix for the musculoskeletal system. This includes a phantom-less QCT bone density detection system, an intelligent orthopedic preoperative planning system, 3D-printed surgical tools, and drug-loaded implants for fracture prevention. Currently, these products are utilized in over 100 clinical hospitals domestically and internationally and have been featured in prominent media outlets, such as Xinwen Lianbo, People's Doctor, CGTN, and People's Daily.
The Bone's Technology team holds over 100 Chinese and global patents and software copyrights. The company has received numerous accolades, including the National Science and Technology Progress Award (Second Class), Forbes Asia Top 100 to Watch, Deloitte Hong Kong Technology Fast 20, Sequoia X-PLAN Leadership Program, AO Trauma Science Award, and the International Osteoporosis Foundation and Bone Research Conference Award.
